Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Details for Australian Patent Application No. 2008320821 (hide)

Owner Abbott GmbH & Co. KG Abbott Laboratories

Inventors Wernet, Wolfgang; Mezler, Mario; Unger, Liliane; Wicke, Karsten; JongenRelo, Ana Lucia; Bespalov, Anton; Lange, Udo; Mayrer, Matthias; Drescher, Karla; Braje, Wilfried; Haupt, Andreas; Turner, Sean Colm; Zhang, Min

Agent Spruson & Ferguson

Pub. Number AU-A-2008320821

PCT Pub. Number WO2009/056632

Priority 61/001,656 02.11.07 US

Filing date 31 October 2008

Wipo publication date 7 May 2009

International Classifications

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/056632 Priority application(s): WO2009/056632

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320822-Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment

2008320820-Molecules and methods for modulating complement component